Cue Biopharma, Inc. (CUE)
Cue Biopharma Market Cap: 26.85M for Jan. 14, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Insmed, Inc. | 34.86B |
| Puma Biotechnology, Inc. | 323.51M |
| Mersana Therapeutics, Inc. | 144.97M |
| Adaptive Biotechnologies Corp. | 2.754B |
| NovaBay Pharmaceuticals, Inc. | 1.604B |
Market Cap Related Metrics
| PS Ratio | 4.140 |
| Price to Book Value | 2.027 |
| Price | 0.341 |
| Earnings Yield | -133.6% |